SetiptilineAlternative Names: MO-8282; MOD-20; ORG-8282; Tecipul; Tesolon
Latest Information Update: 18 Nov 2009
At a glance
- Originator Organon
- Developer Schering-Plough
- Class Dibenzazepines; Tetracyclic antidepressants
- Mechanism of Action Alpha 2 adrenergic receptor antagonists; Serotonin receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Marketed Major depressive disorder